Unknown

Dataset Information

Topical ABT-263 treatment reduces aged skin senescence and improves subsequent wound healing.


ABSTRACT: Senescent cells accumulate in aging tissues, impairing their ability to undergo repair and regeneration following injury. Previous research has demonstrated that targeting tissue senescence with senolytics can enhance tissue regeneration and repair by selectively eliminating SnCs in specific aged tissues. In this study, we focused on eliminating senescent skin cells in aged mice to assess the effects on subsequent wound healing. We applied ABT-263 directly to the skin of 24-month-old mice over a 5-day period. Following topical ABT-263, aged skin demonstrated decreased gene expression of senescence markers p16 and p21, accompanied by reductions in SA-β-gal- and p21-positive cells compared to DMSO controls. However, ABT-263 also triggered a temporary inflammatory response and macrophage infi

SUBMITTER: Shvedova M 

PROVIDER: S-EPMC11810067 | biostudies-literature | 2024 Dec

REPOSITORIES: biostudies-literature